Evidence map›Paper›PMID 21904820›Full record

ArticlePsychopharmacology2012

Synergistic interaction between baclofen administration into the median raphe nucleus and inconsequential visual stimuli on investigatory behavior of rats.

Fiori R Vollrath-Smith, Rick Shin, Satoshi Ikemoto

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Neurocircuitry of drug reward.Neuropharmacology · 2014
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Fiori R Vollrath-SmithBehavioral Neuroscience Branch, National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services, Baltimore, MD 21224, USA.
Rick Shin
Satoshi Ikemoto
National Institute on Drug Abuse · USUnited States Department of Health and Human Services · US

Funding

Intracranial Drug Self AdministrationZ01DA000439 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI IKEMOTO, SATOSHI · 2000 to 2008
$2.4M
Intracranial Drug Self-administrationZIADA000439 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI IKEMOTO, SATOSHI · 2009 to 2013
$2.3M
Post-endocytic Sorting of Opioid ReceptorsK02DA000439 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VONZASTROW, MARK E · 1999 to 2009
$1.1M
Intramural NIH HHS Z01 DA000439Intramural NIH HHS ZIA DA000439NIDA NIH HHS K02 DA000439
6 · The paper itself

Abstract

rationaleNoncontingent administration of amphetamine into the ventral striatum or systemic nicotine increases responses rewarded by inconsequential visual stimuli. When these drugs are contingently administered, rats learn to self-administer them. We recently found that rats self-administer the GABA(B) receptor agonist baclofen into the median (MR) or dorsal (DR) raphe nuclei.

objectivesWe examined whether noncontingent administration of baclofen into the MR or DR increases rats' investigatory behavior rewarded by a flash of light.

resultsContingent presentations of a flash of light slightly increased lever presses. Whereas noncontingent administration of baclofen into the MR or DR did not reliably increase lever presses in the absence of visual stimulus reward, the same manipulation markedly increased lever presses rewarded by the visual stimulus. Heightened locomotor activity induced by intraperitoneal injections of amphetamine (3 mg/kg) failed to concur with increased lever pressing for the visual stimulus. These results indicate that the observed enhancement of visual stimulus seeking is distinct from an enhancement of general locomotor activity. Visual stimulus seeking decreased when baclofen was co-administered with the GABA(B) receptor antagonist, SCH 50911, confirming the involvement of local GABA(B) receptors. Seeking for visual stimulus also abated when baclofen administration was preceded by intraperitoneal injections of the dopamine antagonist, SCH 23390 (0.025 mg/kg), suggesting enhanced visual stimulus seeking depends on intact dopamine signals.

conclusionsBaclofen administration into the MR or DR increased investigatory behavior induced by visual stimuli. Stimulation of GABA(B) receptors in the MR and DR appears to disinhibit the motivational process involving stimulus-approach responses.

Indexed as

AnimalsBaclofenBehavior, AnimalBenzazepinesDopamineExploratory BehaviorGABA-B Receptor AgonistsMaleMorpholinesMotivationMotor ActivityPhotic StimulationRaphe NucleiRatsRats, WistarRewardBaclofenBenzazepinesDopamineGABA-B Receptor AgonistsMorpholines(+)-(S)-5,5-dimethylmorpholinyl-2-acetic acidSCH 23390

Identifiers

PMID21904820
PMCPMC3245792
OpenAlexW2031003082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.